Abstract Worldwide noroviruses are an important cause of gastroenteritis and are major agents of both sporadic as well as epidemic infection. Because of the rapid transmission of the virus, early detection is essential. Until recently, the available test methods for the detection in stool were enzyme immunoassays and real-time reverse transcription polymerase chain reaction (RT-PCR), both of which take several hours to perform. We evaluated the rapid immunochromatographic test RIDA®QUICK Norovirus for the detection of norovirus in the stool of patients with acute gastroenteritis. This test is easy to perform and read and only takes 20 min. The sensitivity and specificity compared to RT-PCR results and the positive and negative predictive values were 57.1%, 99.1%, 93.3% and 91.2%, respectively. The rapid test is useful for quick screening, but a negative result should be followed up by RT-PCR.
Noroviruses (NoVs) have a leading role in causing gastroenteritis worldwide, causing high morbidity rates among patients of all ages [1] . Formerly identified as 'small round structured viruses' and 'Norwalk-like virus,' NoVs are now known as single-stranded RNA viruses, belonging to the genus Norovirus and part of the family Caliciviridae [2] . The genus comprises five genogroups I-V (GI-GV), of which GI, GII and GIV are human pathogens [3] . Strains of GI and GII are the most common agents of gastroenteritis [1] . Gastroenteritis caused by NoV has an incubation period of 24-48 h, although earlier onset does occur. Symptoms usually last 2-3 days and include nausea, vomiting, abdominal cramps, non-bloody diarrhoea and, sometimes, fever [1] . NoV may be acquired from contaminated food or water and is excreted in stool and vomit. Since very low doses of viral particles are infectious, rapid spreading through faecal-oral or airborne transmission easily causes an epidemic, especially in institutions such as hospitals and nursing homes [1] . The rapid detection of NoV in stool is essential in both sporadic cases of gastroenteritis and in outbreak prevention and management. Until recently, the available test methods were reverse transcription polymerase chain reaction (RT-PCR) and enzyme immunoassays (EIAs) for the detection of viral RNA and antigen, respectively. Both methods take several hours to perform, however [4, 5] , whereas the newly developed rapid antigen test RIDA®QUICK Norovirus (RQN assay; R-Biopharm, Darmstadt, Germany) gives a result in approximately 20 min.
We evaluated the RQN assay by testing all stool samples submitted to the Laboratorium voor Medische Microbiologie en Infectieziekten (LMMI), Zwolle, The Netherlands, from patients suspected of NoV infection in the period from January to April 2009 and compared the results to those of a real-time RT-PCR.
The RQN assay is an immunochromatographic test which detects NoV GI and GII in stool. The membrane in the test cassette contains a test line with monoclonal antibodies to NoV attached to it and a control line with anti-mouse IgG. A stool suspension is prepared in dilution buffer. The first conjugate containing biotinylated anti-NoV is added to the supernatant of the suspension and the mix is pipetted into the sample well on the test cassette. The sample migrates along the membrane, crossing the test line and the control line. If NoV is present, antigen-antibody complexes bind to the test line. Unbound anti-NoV binds to the control line. The second conjugate containing streptavidin peroxidase is added to the reaction window on the test cassette, allowing the streptavidin to bind to the biotin. Excess biotin is washed away and the substrate (H 2 O 2 ) with the chromophore tetramethylbenzidine (TMB) is added. Reaction between substrate and TMB turns both test and control lines blue when conjugate is bound to biotinylated antibody. If no NoV is present in the stool sample, only the control line turns blue.
The real-time RT-PCR for the detection of NoV GI and GII was performed at the Laboratory for Infectious Diseases, Groningen, The Netherlands. Stool suspensions were prepared in phosphate-buffered saline and NoV RNA was extracted from the supernatant using the MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche Diagnostics, Almere, The Netherlands), according to the manufacturer's instructions.
First, reverse transcription was performed in a 20-µl reaction containing 5 µl RNA using the TaqMan® Reverse Transcription Reagents kit (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) by incubation at 25°C for 10 min, at 48°C for 30 min and at 95°C for 5 min. Of the obtained cDNA, 10 µl was amplified using an Applied Biosystems 7500 Real-Time PCR System, using primer and probe sets as described by Hoehne et al. [4] , in a 25-µl reaction containing 12.5 µl TaqMan® Universal PCR Master Mix (Applied Biosystems), 15 pmol of each primer and 10 pmol probe by incubation at 50°C for 2 min, at 95°C for 10 min and, subsequently, 40 cycles at 95°C for 15 s and 60°C for 1 min. Appropriate control reactions were included in each RT-PCR run.
In total, 538 stool samples from 420 patients (98 hospitalised patients, 39 nursing home inhabitants, 25 general practice patients and 258 outpatients) were tested. Of these, one sample showed inhibition of the PCR and was excluded. Of the remaining 537 samples, 98 (18.2%) were PCR-positive and 60 (11.2%) were positive by the RQN assay (Table 1) . Using the RT-PCR as the gold standard, the sensitivity, specificity, positive and negative predictive values of the RQN assay were 57.1% (56/98), 99.1% (435/439), 93.3% (56/60) and 91.2% (435/477), respectively.
The sensitivity of the RQN assay was low, but the specificity was excellent. The test allows single sample testing within 20 min and is easy to perform and interpret.
Apostel et al. tested 113 stored stool specimens with the RQN assay and RT-PCR [6] . The sensitivity and specificity of the RQN assay were 86.0% and 94.6%, respectively. They found similar results when the same samples were tested with the RIDASCREEN® Norovirus EIA (RBiopharm), in which NoV GI and GII antigen in stool is detected in a microwell plate (76.8% and 98.2%, respectively). Other studies comparing the RIDASCREEN® Norovirus EIA to RT-PCR reported sensitivities of the EIA between 44% and 76% and specificities between 47% and 96%, which are more consistent with our findings for the RQN assay [7] [8] [9] [10] . The difference between Apostel et al.'s and our RQN assay sensitivity results may be explained by differences between the two patient populations, the prevalent viral genotypes in these populations and the stage of infection at which sampling took place.
The RQN assay and the RIDASCREEN® Norovirus EIA seem to perform equally well, but the rapid RQN assay saves valuable test time compared to the EIA. The lower sensitivities of both the rapid test and the EIA compared to RT-PCR may be explained by the inability of both tests to detect low viral loads. It is important to test well homogenised stool as soon as possible after the onset of symptoms, when viral shedding is highest.
In addition to the most frequently detected GII strains, also, strains belonging to GIV have been reported to cause diarrhoea. La Rosa et al. recently found GIV strains in sewage and in stools from patients with acute gastroenteritis [11] . This indicates that future techniques must be able to detect a wider range of NoV variants.
The rapid immunochromatographic RQN assay is a valuable tool for the rapid screening of NoV infection. Its high specificity enables early confirmation of an outbreak and easy follow-up of positive patients. A negative test result, however, should be followed up by RT-PCR. 
